1. Corporate Officers - M
2. Mcminn Rachel

Insider Trading History of Mcminn Rachel

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Mcminn Rachel since 2015. This trader's CIK number is 1606302. At the time of last reporting, Mcminn Rachel was the Chief Executive Officer of Neurogene Inc.. (stock ticker symbol NGNE). Also see all insider trading activities at Neurogene Inc..

Note that in the past McMinn Rachel also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Intercept Pharmaceuticals, Inc. (ICPT) by Mcminn Rachel

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	ICPT	0	$0	1,857	$191,214	0	$0
2016	ICPT	0	$0	1,191	$167,878	0	$0
2015	ICPT	0	$0	755	$181,641	0	$0

Yearly summary of insider trading at Neurogene Inc. (NGNE) by Mcminn Rachel

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2024	NGNE	47,500	$968,999	0	$0	0	$0

Insider trading activities at 2 companies by Mcminn Rachel:

1. Intercept Pharmaceuticals, Inc. (ICPT)

2. Neurogene Inc. (NGNE)

Table 1. Insider trading of Intercept Pharmaceuticals, Inc. (ICPT) by Mcminn Rachel

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-10-02	ICPT	Sale	283	58.89	16,666
2017-07-31	ICPT	Sale	130	123.12	16,005
2017-07-03	ICPT	Sale	257	121.78	31,297
2017-05-01	ICPT	Sale	114	113.12	12,895
2017-04-03	ICPT	Sale	257	115.00	29,554
2017-01-03	ICPT	Sale	816	103.92	84,797
2016-10-31	ICPT	Sale	129	123.82	15,972
2016-08-01	ICPT	Sale	125	176.56	22,070
2016-07-05	ICPT	Sale	106	145.11	15,381
2016-05-02	ICPT	Sale	130	147.49	19,173
2016-04-04	ICPT	Sale	104	130.76	13,599
2016-02-01	ICPT	Sale	128	103.56	13,255
2016-01-04	ICPT	Sale	469	145.90	68,428
2015-11-02	ICPT	Sale	125	160.24	20,029
2015-07-31	ICPT	Sale	127	262.09	33,285
2015-05-01	ICPT	Sale	503	255.12	128,327

Table 2. Insider trading of Neurogene Inc. (NGNE) by Mcminn Rachel

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2024-11-22	NGNE	Buy	47,500	20.40	968,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcminn Rachel (Chief Executive Officer of Neurogene Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month